CUMULEX (CLEX.BR) Stock Fundamental Analysis
Europe - Euronext Brussels - EBR:CLEX - BE0003463685 - Common Stock
0.745 EUR
0 (0%)
CLEX gets a fundamental rating of 0 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. CLEX has a bad profitability rating. Also its financial health evaluation is rather negative. CLEX does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
- CLEX had negative earnings in the past year.
- CLEX had negative earnings in each of the past 5 years.
- CLEX had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
- The profitability ratios for CLEX are negative, so there is not much use analyzing them.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | N/A | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Profit Margin and Operating Margin and Gross Margin are not available for CLEX so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- Compared to 1 year ago, CLEX has about the same amount of shares outstanding.
- The number of shares outstanding for CLEX has been reduced compared to 5 years ago.
- CLEX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | N/A |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0 | ||
| Quick Ratio | 0 |
3. Growth
3.1 Past
- The earnings per share for CLEX have decreased strongly by -17.10% in the last year.
EPS 1Y (TTM)-17.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%9.56%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
3.2 Future
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for CLEX. In the last year negative earnings were reported.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
- CLEX does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
CUMULEX / CLEX.BR FAQ
What is the ChartMill fundamental rating of CUMULEX (CLEX.BR) stock?
ChartMill assigns a fundamental rating of 0 / 10 to CLEX.BR.
What is the valuation status of CUMULEX (CLEX.BR) stock?
ChartMill assigns a valuation rating of 0 / 10 to CUMULEX (CLEX.BR). This can be considered as Overvalued.
Can you provide the profitability details for CUMULEX?
CUMULEX (CLEX.BR) has a profitability rating of 0 / 10.